The global intravenous equipment market encompasses all devices used for intravenous therapy including infusion pumps, IV catheters, administration sets, securement devices, needleless systems, closed systems and safety technologies that support fluid delivery, medication administration, blood transfusions and parenteral nutrition across hospitals, clinics and ambulatory care and homecare settings. This market is expanding due to a rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders and renal failure which require frequent and long term intravenous therapy, increasing number of surgical procedures worldwide, and the growing focus on patient safety, infection control and clinical efficiency. Regulatory frameworks in major markets such as the United States, Europe, Japan, China and other regions play a critical role in shaping the industry by ensuring that intravenous equipment meets strict quality, safety and performance standards. Many regulatory authorities are aligning their requirements with international standards such as ISO norms for medical devices to streamline approvals and enhance global harmonization .
Governments and health ministries are also promoting policies that emphasize infection prevention, needlestick injury reduction and patient safety, which drives the adoption of advanced IV technologies including needleless connectors, integrated closed systems and smart infusion pumps that reduce the risk of contamination and medication errors. Reimbursement frameworks in developed markets are adapting to support outpatient and home based IV therapy, providing opportunities for growth in portable and ambulatory infusion devices that allow patients to receive treatment outside traditional hospital environments.
According to the research report "Global Intravenous Equipment Market Outlook, 2031," published by Bonafide Research, the Global Intravenous Equipment market was valued at more than USD 16.72 Billion in 2025, and expected to reach a market size of more than USD 23.99 Billion by 2031 with the CAGR of 6.37% from 2026-2031. Partnerships between global manufacturers and local distributors improve access to advanced IV solutions in emerging markets, enabling faster regulatory navigation, broader distribution, and clinician training that supports adoption of complex technologies in diverse care settings. Growth in the market is also influenced by international trade in raw materials and components such as medical grade polymers, precision electronics, microfluidic assemblies, sensors and sterile packaging that are sourced from manufacturing hubs in North America, Europe and Asia and assembled into finished equipment for global distribution. Countries with strong manufacturing capabilities export finished IV devices to markets with growing healthcare demands while importing specialized components to support quality production .
Technological developments continue to reshape the landscape with smart infusion pumps offering real time monitoring, automated dose adjustments, alarm management and integration with hospital networks to reduce medication errors and enhance safety. Integrated closed system devices that minimize contamination risk and portable ambulatory infusion systems support the growing trend toward homecare therapy and decentralized healthcare delivery. Important global events such as international medical expos and healthcare technology conferences facilitate knowledge exchange among clinicians, regulators and industry innovators, showcasing breakthroughs like AI enabled infusion monitoring and predictive maintenance capabilities.
IV securement devices are designed to stabilize catheters, prevent accidental dislodgement, reduce movement at the insertion site, and minimize the risk of complications such as infiltration, phlebitis, and catheter related bloodstream infections. The growing awareness of these risks among healthcare professionals, coupled with stringent hospital protocols for infection control and patient safety, has significantly contributed to the accelerated adoption of securement devices .
Regulatory frameworks in developed markets such as the United States, Europe, and Japan require healthcare facilities to implement measures that reduce catheter related complications and needlestick injuries, which further drives the demand for advanced securement solutions. Technological innovations in this segment include adhesive securement devices, stabilization dressings, sutureless securement systems, and integrated catheter stabilization platforms that offer improved comfort, ease of use, and compatibility with various catheter types and infusion systems. Hospitals and clinics, which are the largest users of intravenous equipment, prefer securement devices because they help reduce nurse workload, minimize treatment interruptions, and enhance patient outcomes by maintaining catheter patency over extended periods, especially in critical care and oncology wards where long term intravenous therapy is common. The increasing prevalence of chronic diseases such as cancer, diabetes, kidney failure, and cardiovascular disorders has resulted in more frequent and prolonged IV therapy sessions, which further accentuates the need for reliable securement solutions to prevent dislodgement and associated complications .
Homecare settings and ambulatory infusion therapy are also contributing to the growth of IV securement devices, as patients receiving therapy outside hospitals require stable, easy to apply, and low risk solutions to maintain catheter positioning safely.
Home care intravenous therapy allows patients with chronic illnesses, post-surgical recovery needs, cancer treatments, or long-term nutritional support to receive essential IV therapies safely in the comfort of their homes, reducing the risk of hospital-acquired infections and enhancing overall quality of life. Technological advancements in portable infusion pumps, prefilled IV systems, needleless connectors, and integrated closed systems have made home administration of intravenous therapies safer, easier, and more reliable, allowing patients and caregivers to manage complex treatment regimens with minimal clinical supervision. The growth of the segment is further supported by healthcare policies and reimbursement frameworks in developed countries that incentivize outpatient and home-based care as a cost-effective alternative to prolonged hospital admissions. Additionally, rising patient awareness about homecare benefits, convenience, and early intervention has fueled the adoption of home-based IV therapies, particularly in oncology, nephrology, and chronic disease management where frequent and long-term IV interventions are required .
Manufacturers are responding to this trend by developing compact, lightweight, user-friendly devices that ensure accurate fluid delivery, alarm notifications for dose completion or occlusions, and connectivity with telehealth monitoring systems to allow remote clinical oversight, further supporting safe and effective homecare therapy. The prevalence of chronic diseases such as cancer, renal disorders, diabetes, and cardiovascular conditions has significantly increased the volume of patients eligible for home IV therapy, driving sustained demand for portable infusion equipment, securement devices, and safety systems designed for non-hospital environments.
Integrated closed systems are designed to maintain a sterile environment during intravenous therapy by preventing exposure of fluids and catheters to external contaminants, thereby reducing the risk of catheter related bloodstream infections, infiltration, and other complications. These systems typically combine multiple functions such as infusion, sampling, and medication delivery into a single closed device, simplifying the workflow for healthcare professionals and minimizing handling errors. Hospitals, dialysis centers, oncology wards, and homecare settings increasingly prefer these systems because they offer consistent fluid delivery, improve medication accuracy, and enhance patient comfort while lowering the need for repeated vascular access procedures .
Regulatory authorities including the US Food and Drug Administration, European Medicines Agency, and equivalent bodies in other regions strongly support the adoption of closed systems, particularly in high risk environments, as part of broader infection prevention and patient safety policies. Technological advancements in this segment include needleless connectors, prefilled IV systems, anti reflux valves, and automated infusion platforms that integrate real-time monitoring, alarm notifications, and electronic health record connectivity to reduce clinical errors and enhance remote supervision in homecare and outpatient settings. The adoption of integrated closed systems is also fueled by the rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and renal failure, which require long-term intravenous therapy and repeated vascular access, making secure, efficient, and sterile delivery systems critical to improving treatment outcomes.
